Emyria Limited
EMD
Rank in Stocks
#26465
Emyria Limited is a biotechnology firm currently in the clinical stage,... Emyria Limited is a biotechnology firm currently in the clinical stage, dedicated to creating therapies for medical conditions that lack effective treatments. The company's work primarily involves the development of cannabinoid-derived pharmaceuticals, alongside an initiative for discovering new MDMA-based drugs. Among its pipeline, EMD-RX5 is being explored for psychological distress and irritable bowel syndrome, while EMD-RX7 targets a variety of medical conditions. Established in 2018 and based in Leederville, Australia, the company adopted its current name, Emyria Limited, in September 2020, having previously operated as Emerald Clinics Limited.
Share Price
$0.02491884
Last synced: 2026-11-10
Market Cap
$20.10M
Change (1 day)
0.00%
Change (1 year)
-48.40%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Emyria Limited (EMD)
Category
Healthcare
EPS for Emyria Limited (EMD)
EPS as of June 2026 TTM: $-0.01
According to Emyria Limited's latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of 0.00, an increase over its 2024 EPS of $-0.02.
EPS history for Emyria Limited from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -78.40% |
| 2025 | 0.00 | -78.40% |
| 2024 | $-0.02 | 80.51% |
| 2023 | $-0.01 | -37.23% |
| 2022 | $-0.02 | 12.57% |
| 2021 | $-0.02 | -19.71% |
| 2020 | $-0.02 | 116.67% |
| 2019 | $-0.01 | 4,700.00% |
| 2018 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.86 | -67,819.30% |
US
|
|
| $-1.05 | 18,321.05% |
US
|
|
| $1.79 | -31,543.86% |
AU
|
|
| $1.64 | -28,871.93% |
US
|
|
| $2.08 | -36,591.23% |
US
|
Questions about Emyria Limited's earnings per share (EPS)
What is Emyria Limited's earnings per share (EPS)?
Emyria Limited's earnings per share (EPS) over the last twelve months is $-0.01, as of Jun 2026.
What was Emyria Limited's earnings per share (EPS) in 2025?
In 2025, Emyria Limited's earnings per share (EPS) was 0.00, compared with $-0.02 in 2024.
How has Emyria Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Emyria Limited's earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2024 ($-0.02).
How does Emyria Limited's earnings per share (EPS) compare with similar companies?
Emyria Limited's earnings per share (EPS) ($-0.01) is higher than that of 1 of the 5 similar companies listed above. The highest among them is GE HealthCare Technologies Inc., with $3.86.